Assessment of circulating copy number variant detection for cancer screening

PLoS ONE

Volumn 12, Issue 7, 2017, Pages

  Molparia, Bhuvan ^a,b   Nichani, Eshaan ^c   Torkamani, Ali ^a,b,d  

^a SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d SCRIPPS HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULATING TUMOR DNA; DNA; UNCLASSIFIED DRUG; TUMOR MARKER;

ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SCREENING; CIRCULATING TUMOR CELL; COMPUTER MODEL; COPY NUMBER VARIATION; GENE MAPPING; GENOME; HUMAN; NORMAL HUMAN; POINT MUTATION; SEQUENCE ANALYSIS; BLOOD; CANCER STAGING; EARLY CANCER DIAGNOSIS; GENETICS; NEOPLASM; PATHOLOGY; TUMOR EMBOLISM;

BIOMARKERS, TUMOR; DNA COPY NUMBER VARIATIONS; DNA, NEOPLASM; EARLY DETECTION OF CANCER; HUMANS; NEOPLASM STAGING; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; POINT MUTATION;

EID: 85022326717     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0180647     Document Type: Article

References (43)

1. Suh KS, Park SW, Castro A, Patel H, Blake P, Liang M, et al. Ovarian cancer biomarkers for molecular biosensors and translational medicine. Expert review of molecular diagnostics. 2010; 10(8):1069–83. https://doi.org/10.1586/erm.10.87 PMID: 21080822.
2. Menon U, Gentry-Maharaj A, Hallett R, Ryan A, Burnell M, Sharma A, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKC-TOCS). The Lancet Oncology. 2009; 10(4):327–40. https://doi.org/10.1016/S1470-2045(09)70026-9PMID: 19282241.
3. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Annals of internal medicine. 2011; 155(8):481–92. https://doi.org/10.7326/0003-4819-155-8-201110180-00004 PMID: 22007042; PubMed Central PMCID: PMC3209800.
4. Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, et al. Multitarget stool DNA testing for colorectal-cancer screening. The New England journal of medicine. 2014; 370(14):1287–97. https://doi.org/10.1056/NEJMoa1311194 PMID: 24645800.
5. Punglia RS, D’Amico AV, Catalona WJ, Roehl KA, Kuntz KM. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. The New England journal of medicine. 2003; 349(4):335–42. https://doi.org/10.1056/NEJMoa021659 PMID: 12878740.
6. Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA. 2011; 305(22):2295–303. https://doi.org/10.1001/jama.2011.766 PMID: 21642681.
7. Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nature medicine. 2014; 20(5):548–54. https://doi.org/10.1038/nm.3519 PMID: 24705333; PubMed Central PMCID: PMCPMC4016134.
8. Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. The New England journal of medicine. 2013; 368(13):1199–209. https://doi.org/10.1056/NEJMoa1213261 PMID: 23484797.
9. Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Science translational medicine. 2014; 6 (224):224ra24. https://doi.org/10.1126/scitranslmed.3007094 PMID: 24553385; PubMed Central PMCID: PMCPMC4017867.
10. Crowley E, Di Nicolantonio F, Loupakis F, Bardelli A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol. 2013; 10(8):472–84. https://doi.org/10.1038/nrclinonc.2013.110 PMID: 23836314.
11. Heidary M, Auer M, Ulz P, Heitzer E, Petru E, Gasch C, et al. The dynamic range of circulating tumor DNA in metastatic breast cancer. Breast Cancer Res. 2014; 16(4):421. https://doi.org/10.1186/s13058-014-0421-y PMID: 25107527; PubMed Central PMCID: PMCPMC4303230.
12. Chan KC, Jiang P, Zheng YW, Liao GJ, Sun H, Wong J, et al. Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin Chem. 2013; 59(1):211–24. https://doi.org/10.1373/clinchem.2012.196014 PMID: 23065472.
13. Leary RJ, Sausen M, Kinde I, Papadopoulos N, Carpten JD, Craig D, et al. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Science translational medicine. 2012; 4(162):162ra54. https://doi.org/10.1126/scitranslmed.3004742 PMID: 23197571; PubMed Central PMCID: PMC3641759.
14. Shlien A, Malkin D. Copy number variations and cancer. Genome medicine. 2009; 1(6):62. https://doi.org/10.1186/gm62 PMID: 19566914; PubMed Central PMCID: PMC2703871.
15. Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, et al. Mutational landscape and significance across 12 major cancer types. Nature. 2013; 502(7471):333–9. https://doi.org/10.1038/nature12634PMID: 24132290; PubMed Central PMCID: PMC3927368.
16. Carrasco DR, Tonon G, Huang Y, Zhang Y, Sinha R, Feng B, et al. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell. 2006; 9 (4):313–25. https://doi.org/10.1016/j.ccr.2006.03.019 PMID: 16616336.
17. Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell. 2014; 158 (4):929–44. https://doi.org/10.1016/j.cell.2014.06.049 PMID: 25109877; PubMed Central PMCID: PMC4152462.
18. Hofree M, Shen JP, Carter H, Gross A, Ideker T. Network-based stratification of tumor mutations. Nature methods. 2013; 10(11):1108–15. https://doi.org/10.1038/nmeth.2651 PMID: 24037242; PubMed Central PMCID: PMCPMC3866081.
19. Heitzer E, Ulz P, Belic J, Gutschi S, Quehenberger F, Fischereder K, et al. Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing. Genome medicine. 2013; 5(4):30. https://doi.org/10.1186/gm434 PMID: 23561577; PubMed Central PMCID: PMCPMC3707016.
20. Kirkizlar E, Zimmermann B, Constantin T, Swenerton R, Hoang B, Wayham N, et al. Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a
21. Massively Multiplexed PCR Methodology. Transl Oncol. 2015; 8(5):407–16. https://doi.org/10.1016/j.tranon.2015.08.004 PMID: 26500031; PubMed Central PMCID: PMCPMC4631096.
22. Bianchi DW, Chudova D, Sehnert AJ, Bhatt S, Murray K, Prosen TL, et al. Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies. JAMA. 2015; 314(2):162–9. https://doi.org/10.1001/jama.2015.7120 PMID: 26168314.
23. Amant F, Verheecke M, Wlodarska I, Dehaspe L, Brady P, Brison N, et al. Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing. JAMA Oncol. 2015; 1 (6):814–9. https://doi.org/10.1001/jamaoncol.2015.1883 PMID: 26355862.
24. Lefkowitz RB, Tynan JA, Liu T, Wu Y, Mazloom AR, Almasri E, et al. Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants. Am J Obstet Gynecol. 2016. https://doi.org/10.1016/j.ajog.2016.02.030 PMID: 26899906.
25. Nygren AOH, Dean J, Jensen TJ, Kruse S, Kwong W, van den Boom D, et al. Quantification of Fetal DNA by Use of Methylation-Based DNA Discrimination. Clinical Chemistry. 2010; 56(10):1627–35. https://doi.org/10.1373/clinchem.2010.146290 PMID: 20729299
26. Fan HC, Gu W, Wang J, Blumenfeld YJ, El-Sayed YY, Quake SR. Non-invasive prenatal measurement of the fetal genome. Nature. 2012; 487(7407):320–4. https://doi.org/10.1038/nature11251 PMID: 22763444; PubMed Central PMCID: PMC3561905.
27. Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B, et al. Pan-cancer patterns of somatic copy number alteration. Nature genetics. 2013; 45(10):1134–40. https://doi.org/10.1038/ng. 2760 PMID: 24071852; PubMed Central PMCID: PMC3966983.
28. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010; 463(7283):899–905. https://doi.org/10.1038/nature08822 PMID: 20164920; PubMed Central PMCID: PMCPMC2826709.
29. Fernández-Delgado M, Cernadas E, Barro S, Amorim D. Do we Need Hundreds of Classifiers to Solve Real World Classification Problems?. Journal of Machine Learning Research. 2014; 15:3133–81.
30. Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of onco-genic signatures across human cancers. Nature genetics. 2013; 45(10):1127–33. https://doi.org/10.1038/ng.2762 PMID: 24071851; PubMed Central PMCID: PMC4320046.
31. Zbar B, Brauch H, Talmadge C, Linehan M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature. 1987; 327(6124):721–4. https://doi.org/10.1038/327721a0 PMID: 2885753.
32. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014; 30(15):2114–20. https://doi.org/10.1093/bioinformatics/btu170 PMID: 24695404; PubMed Central PMCID: PMCPMC4103590.
33. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754–60. https://doi.org/10.1093/bioinformatics/btp324 PMID: 19451168; PubMed Central PMCID: PMCPMC2705234.
34. Anders S, Pyl PT, Huber W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015; 31(2):166–9. https://doi.org/10.1093/bioinformatics/btu638 PMID: 25260700; PubMed Central PMCID: PMCPMC4287950.
35. Rousseeuw PJ, Hubert M. Robust statistics for outlier detection. Wiley Interdisciplinary Reviews: Data Mining and Knowledge Discovery. 2011; 1(1):73–9. https://doi.org/10.1002/widm.2
36. Fan HC, Quake SR. Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics. PloS one. 2010; 5(5):e10439. https://doi.org/10.1371/journal.pone.0010439 PMID: 20454671; PubMed Central PMCID: PMCPMC2862719.
37. Hupe P, Stransky N, Thiery JP, Radvanyi F, Barillot E. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics. 2004; 20(18):3413–22. https://doi.org/10.1093/bioinformatics/bth418 PMID: 15381628.
38. Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics. 2004; 5(4):557–72. https://doi.org/10.1093/biostatistics/kxh008 PMID: 15475419.
39. Erikson GA, Deshpande N, Kesavan BG, Torkamani A. SG-ADVISER CNV: copy-number variant annotation and interpretation. Genetics in medicine: official journal of the American College of Medical Genetics. 2014. https://doi.org/10.1038/gim.2014.180 PMID: 25521334.
40. Genomes Project C, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012; 491(7422):56–65. https://doi.org/10.1038/nature11632 PMID: 23128226; PubMed Central PMCID: PMC3498066.
41. Borrell B. Sequencing projects bring age-old wisdom to genomics. Nature medicine. 2011; 17(11):1329. https://doi.org/10.1038/nm1111-1329a PMID: 22064397.
42. Singleton MV, Guthery SL, Voelkerding KV, Chen K, Kennedy B, Margraf RL, et al. Phevor combines multiple biomedical ontologies for accurate identification of disease-causing alleles in single individuals and small nuclear families. American journal of human genetics. 2014; 94(4):599–610. https://doi.org/10.1016/j.ajhg.2014.03.010 PMID: 24702956; PubMed Central PMCID: PMC3980410.
43. Lin J, Keogh E, Lonardi S, Chiu B. A Symbolic Representation of Time Series, with Implications for Streaming Algorithms. In proceedings of the 8th ACM SIGMOD Workshop on Research Issues in Data Mining and Knowledge Discovery. 2003.